<?xml version="1.0" encoding="UTF-8"?>
<xml>
<records>
<record>
  <contributors>
    <authors>
      <author>Gomollón, Fernando</author>
      <author>Louro, Javier</author>
      <author>López Pérez, Juan</author>
      <author>Nocito Colon, María Mercedes</author>
      <author>Gallego Llera, Beatriz</author>
      <author>García-Mateo, Sandra</author>
      <author>Martínez-Domínguez, Samuel J</author>
      <author>Aso Gonzalvo, María Concepción</author>
      <author>Gargallo-Puyuelo, Carla J</author>
      <author>López De-La-Cruz, Julia</author>
    </authors>
  </contributors>
  <titles>
    <title>Impact of HLADQA1*05 and HLADQA1*03 on Safety and Loss of Response to Anti-Tumor Necrosis Factor in Patients With Inflammatory Bowel Disease</title>
    <secondary-title>J. Crohns  Colitis</secondary-title>
  </titles>
  <doi>10.1093/ecco-jcc/jjae178</doi>
  <pages/>
  <volume/>
  <number/>
  <dates>
    <year>2024</year>
    <pub-dates>
      <date>2024</date>
    </pub-dates>
  </dates>
  <abstract/>
</record>

</records>
</xml>